MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202541021719 A) filed by Shilpa Medicare Limited on March 11, 2025, for Ondansetron Extendable Release Injectable Suspension And Methods Of Use.
Inventor includes Veerendra Kumar Panuganti.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: The present disclosure provides an extended release suspension comprising ondansetron and methods of treating or preventing nausea in a subject using the same. The extended release suspension is suitable for intramuscular injection wherein a single dose provides a plasma concentration of ondansetron, or a metabolite thereof, of above about 10 ng/ml or more for a period of at least four days after administration to a subject.
Disclaimer: Curated by HT Syndication.
